Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe

被引：0
|
作者：
Julien Taieb
Thomas Seufferlein
Michele Reni
Daniel H. Palmer
John A. Bridgewater
Antonio Cubillo
Gerald W. Prager
Alice Vermeire
Fabienne Hédouin-Biville
Zhaoyang Teng
Teresa Macarulla
机构：
[1] Université de Paris,Department of Gastroenterology and Digestive Oncology
[2] Georges Pompidou European Hospital,Department of Internal Medicine I
[3] SIRIC CARPEM,Department of Medicine I
[4] Université Paris-Cité,Vall d´Hebron University Hospital
[5] Hôpital Européen Georges Pompidou,undefined
[6] Hepatogastroenterology and GI Oncology,undefined
[7] University Hospital Ulm,undefined
[8] University Vita E Salute,undefined
[9] IRCCS,undefined
[10] San Raffaele Scientific Institute,undefined
[11] University of Liverpool,undefined
[12] UCL Cancer Institute,undefined
[13] HM CIOCC University Hospital,undefined
[14] Medical University of Vienna,undefined
[15] Servier,undefined
[16] Servier Pharmaceuticals,undefined
[17] Vall d´Hebron Institute of Oncology (VHIO),undefined
[18] IOB Quiron,undefined
来源：
BMC Cancer | / 23卷
关键词：
Pancreatic cancer; Metastatic; Survival; Prognostic factors; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Adverse events in real-world patients covered by Medicare with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
    Dieguez, Gabriela
    Tomicki, Samantha
    Cockrum, Paul
    Hirsch, Jared
    Bhatt, Prachi
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
    Santoni, Matteo
    Heng, Daniel Y.
    Bracarda, Sergio
    Procopio, Giuseppe
    Milella, Michele
    Porta, Camillo
    Matrana, Marc R.
    Carteni, Giacomo
    Crabb, Simon J.
    De Giorgi, Ugo
    Basso, Umberto
    Masini, Cristina
    Calabro, Fabio
    Vitale, Maria Giuseppa
    Santini, Daniele
    Massari, Francesco
    Galli, Luca
    Fornarini, Giuseppe
    Ricotta, Riccardo
    Buti, Sebastiano
    Zucali, Paolo
    Caffo, Orazio
    Morelli, Franco
    Carrozza, Francesco
    Martignetti, Angelo
    Gelibter, Alain
    Iacovelli, Roberto
    Mosca, Alessandra
    Atzori, Francesco
    Vau, Nuno
    Incorvaia, Lorena
    Ortega, Cinzia
    Scarpelli, Marina
    Lopez-Beltran, Antonio
    Cheng, Liang
    Paolucci, Vittorio
    Graham, Jeffrey
    Pierce, Erin
    Scagliarini, Sarah
    Sepe, Pierangela
    Verzoni, Elena
    Merler, Sara
    Rizzo, Mimma
    Sorgentoni, Giulia
    Conti, Alessandro
    Piva, Francesco
    Cimadamore, Alessia
    Montironi, Rodolfo
    Battelli, Nicola
    CANCERS, 2020, 12 (01)
  • [43] Third-line treatment options in metastatic pancreatic cancer patients: a real-world study
    Lu, Hong-Rui
    Zhu, Peng-Fei
    Deng, Ya-Ya
    Chen, Zhe-Ling
    Yang, Liu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Development and Validation of the Predictive and Prognostic ChemoResist Signature in Resected Pancreatic Ductal Adenocarcinoma: Multicohort Study
    Huang, Lei
    Han, Quanli
    Zhao, Liangchao
    Wang, Zhikuan
    Dai, Guanghai
    Shi, Yan
    ANNALS OF SURGERY, 2025, 281 (04) : 632 - 644
  • [45] Prognostic score for synchronous metastatic rectal cancer: A real-world study
    Muzellec, Lea
    Campion, Loic
    Bachet, Jean-Baptiste
    Taieb, Julien
    Fremont, Elodie
    Senellart, Helene
    Moreau, Johanna
    Bouche, Olivier
    Garric, Marie
    Guimbaud, Rosine
    Greilsamer, Charlotte
    Bodere, Anais
    Lievre, Astrid
    Girot, Paul
    Edeline, Julien
    Tougeron, David
    Bennouna, Jaafar
    Touchefeu, Yann
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (10) : 1411 - 1416
  • [46] Real-world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real-world data project
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (06)
  • [47] Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma
    Omar Abdel-Rahman
    Jennifer Spratlin
    Sheryl Koski
    Medical Oncology, 2021, 38
  • [48] Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma
    Abdel-Rahman, Omar
    Spratlin, Jennifer
    Koski, Sheryl
    MEDICAL ONCOLOGY, 2021, 38 (02)
  • [49] Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
    Stavraka, Chara
    Pouptsis, Athanasios
    Synowiec, Alicja
    Angelis, Vasileios
    Satterthwaite, Liyana
    Khan, Sam
    Chauhan, Meera
    Holden, Chloe
    Young, Sally
    Karampera, Christina
    Martinou, Maria
    Mills-Baldock, Tina
    Baxter, Mark
    Barry, Ainsley
    Eccles, Bryony
    Iveson, Timothy
    Shiu, Kai-Keen
    Hill, Mark
    Abdel-Raouf, Sherif
    Graham, Janet Shirley
    Thomas, Anne
    Ross, Paul J.
    CLINICAL COLORECTAL CANCER, 2021, 20 (04) : 342 - 349
  • [50] Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
    Kang, Sora
    Yoo, Changhoon
    Lee, So Heun
    Oh, Dongwook
    Song, Tae Jun
    Lee, Sang Soo
    Jeong, Jae Ho
    Park, Do Hyun
    Seo, Dong Wan
    Park, Jin-hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Kwak, Bong Jun
    Hong, Sarang
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Kim, Kyu-pyo
    Kim, Song Cheol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
12345